Huang S, Varani J, Chakrabarty S
Division of Laboratory Medicine, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
J Cell Physiol. 1994 Dec;161(3):470-82. doi: 10.1002/jcp.1041610310.
Results of previous studies show that the expression of fibronectin and its cell-surface fibronectin binding receptor is coregulated in 3-methylchloranthrene transformation of normal AKR-2B cells to form AKR-MCA cells and in N,N,-dimethylformamide (DMF) induction of differentiation of transformed AKR-MCA cells (1990, J. Cell. Physiol., 143:445). In this study, we tested the coregulation hypothesis by transfection experiments using an antisense fibronectin expression vector. We determined the effect of antisense fibronectin RNA expression on untransformed AKR-2B cells, and on the responses of transformed AKR-MCA cells to DMF treatment. Expression of antisense fibronectin RNA in AKR-2B cells down-modulated fibronectin production, reduced adhesion to extracellular fibronectin, and altered cellular morphology. Saturation binding and Scatchard analyses using radiolabelled fibronectin revealed a concurrent down-modulation of cell-surface fibronectin binding sites, but the binding affinity of the receptor for the ligand was not affected. Immunoblotting and immunostaining revealed down-modulation of the expression of alpha 5 beta 1 integrins. Expression of antisense fibronectin RNA in AKR-MCA cells down-modulated the ability of DMF to restore normal fibronectin production, cell-surface fibronectin binding receptor, adhesion to extracellular fibronectin, and cellular morphology. These studies show that both fibronectin and its cell-surface fibronectin binding receptor were tightly regulated during transformation and induction of differentiation in these cells, that the ligand and its cell-surface fibronectin binding receptor worked together to bring about phenotypic changes, and that fibronectin production regulated the expression of its cell-surface fibronectin binding receptor.
先前的研究结果表明,在正常AKR - 2B细胞转化为AKR - MCA细胞的3 - 甲基氯蒽转化过程中,以及在转化的AKR - MCA细胞的N,N - 二甲基甲酰胺(DMF)诱导分化过程中,纤连蛋白及其细胞表面纤连蛋白结合受体的表达是共同调节的(1990年,《细胞生理学杂志》,143:445)。在本研究中,我们通过使用反义纤连蛋白表达载体的转染实验来检验共同调节假说。我们确定了反义纤连蛋白RNA表达对未转化的AKR - 2B细胞的影响,以及对转化的AKR - MCA细胞对DMF处理反应的影响。AKR - 2B细胞中反义纤连蛋白RNA的表达下调了纤连蛋白的产生,降低了对细胞外纤连蛋白的粘附,并改变了细胞形态。使用放射性标记的纤连蛋白进行的饱和结合和Scatchard分析显示细胞表面纤连蛋白结合位点同时下调,但受体对配体的结合亲和力未受影响。免疫印迹和免疫染色显示α5β1整合素的表达下调。AKR - MCA细胞中反义纤连蛋白RNA的表达下调了DMF恢复正常纤连蛋白产生、细胞表面纤连蛋白结合受体、对细胞外纤连蛋白的粘附以及细胞形态的能力。这些研究表明,在这些细胞的转化和分化诱导过程中,纤连蛋白及其细胞表面纤连蛋白结合受体均受到严格调节,配体及其细胞表面纤连蛋白结合受体共同作用导致表型变化,并且纤连蛋白的产生调节其细胞表面纤连蛋白结合受体的表达。